Distalmotion Secures Strategic Investment to Advance ASC Expansion of the DEXTER® Robotic Surgery System Distalmotion, the ...

U.S. orthopedic soft tissue repair hit $2.3B in 2024, projected near $3.4B by 2031, driven by outpatient arthroscopy ...

Viper Partners, the leading investment banking and M&A advisory firm specializing in healthcare and aesthetics since 2009, ...

As we start 2026, orthopedic surgeons have a remarkable opportunity to remain at the forefront of the innovation of joint ...

IDH-mutant glioma, caused by abnormalities in a specific gene (IDH), is the most common malignant brain tumor among young ...

The FDA and European Medicines Agency (EMA) have awarded orphan drug designation to CPI-008 (cRGD-ZW800-1), a novel ...

The Reddit cofounder isn’t letting online chatter about his wife’s appearance slide, stepping in to defend the tennis icon ...

Epithelioma Treatment Market to reach USD 13.1 billion by 2035, driven by rising skin cancer cases and growing adoption of ...

In Brazil, the early detection of genetic alterations in lung cancer through liquid biopsies could be a valuable tool for ...

WONTECH Debuts Non-Contact Biometric Monitoring and Converged Pain Treatment Solutions LAS VEGAS, NV, UNITED STATES, ...

CARY, N.C., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Heron Therapeutics, Inc. (Nasdaq: HRTX) (“Heron” or the “Company”), a commercial-stage biotechnology company, today announced preliminary, unaudited ...

VIVUS LLC, a biopharmaceutical company committed to the development and commercialization of innovative therapies that focus on advancing treatments for patients with serious unmet medical needs, ...